Ronald Coury Tisdale, MD
Family Practice · Selma
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 9 years
- Icahn School of Medicine at Mount Sinai, 2017
Offices
1 location · Paragon Contracting Services LLC · 404 clinicians in this group
Looking this up.
Hospitals listed: Vaughan Regional Medical Center Parkway Campus. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tisdale’s office at (334) 418-5999 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Vaughan Regional Medical Center Parkway CampusSelma, ALAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of ScionHealth, which runs 82 hospitals in 28 statesPatients rate it 2 of 5 · 47% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Vaughan Regional Medical Center Parkway Campus
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 67 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.48 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.1 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.4 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17 · 97 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 19.9 · 83 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.7 · 756 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,135 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.39 (0.18 to 0.61) · 1,148 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (0.81 to 6.03) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.04) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.44 (0 to 1.56) · 781 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.862 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 49 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 208 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 39.4 · 75 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -20.5 · 94 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 193 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.8 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.2 to 16.6) · 181 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 35 cases | No different | Jan 2024 – Dec 2024 |
What patients said (305 patients answered, 12% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 1 |
| Overall hospital rating | 2 |
| Quietness | 4 |
| Recommend hospital | 1 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 77% |
| Yes, staff "did" give patients information about help after discharge | 74% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 55% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 71% |
| "YES", patients would definitely recommend the hospital | 47% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 79% |
Original Medicare doctor bills
$18,142
Medicare paid this office $18,142 for 142 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Emergency department visit with high level of medical decision making | 100 | $13,348 | $124 |
| Emergency department visit with moderate level of medical decision making | 31 | $2,767 | $84 |
Who their Medicare patients are
142 Original Medicare patients in 2024. Average age 73 · Under 65 20% · 85 and older 20% · Women 61% · Also on Medicaid 50% · Health risk score 2.47. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 54% · Chronic kidney disease 46% · Coronary heart disease 43% · Heart failure 39% · Dementia 33% · COPD 32% · Depression 30% · Stroke 23% · Atrial fibrillation 20% · Cancer 13%.
The office billed $280,955, Medicare allowed $23,451 and paid $18,142; for 174 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 142 | 174 | 73 | 2.47 | $280,955 | $18,142 |
| 2023 | 150 | 172 | 70 | 2.39 | $296,884 | $19,721 |
| 2022 | 97 | 122 | 70 | 1.87 | $178,278 | $12,911 |
| 2021 | 82 | 89 | 72 | 1.36 | $104,665 | $8,929 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Emergency department visit with high level of medical decision making | 101 | $14,768 | $131 |
| Emergency department visit with moderate level of medical decision making | 29 | $2,402 | $80 |
2022: 4 services
| Emergency department visit with high level of medical decision making | 64 | $9,189 | $144 |
| Emergency department visit with moderate level of medical decision making | 20 | $1,934 | $97 |
| Emergency department visit with low level of medical decision making | 12 | $591 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 17 | $114 | $6 |
2021: 3 services
| Emergency department visit with high level of medical decision making | 35 | $5,117 | $142 |
| Emergency department visit with moderate level of medical decision making | 22 | $2,227 | $97 |
| Emergency department visit with low level of medical decision making | 18 | $1,025 | $57 |
Medicaid work
$150,030 in 2024
Medicaid paid $150,030 for 3,272 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 482 | $83,652 |
| EMERGENCY DEPT VISIT MOD MDM | 381 | $22,627 |
| 3D RENDER W/INTRP POSTPROCES | 134 | $9,234 |
| EMERGENCY DEPT VISIT LOW MDM | 214 | $9,180 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 136 | $5,826 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 20 | $4,200 |
| COMPREHENSIVE METABOLIC PANEL | 333 | $3,848 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 376 | $3,607 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 172 | $2,235 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 261 | $1,038 |
| Troponin, quantitative | 87 | $874 |
| Radiologic examination, chest; single view | 147 | $769 |
| 2024 | 3,272 | 21 | 38 | $150,030 |
| 2023 | 6,702 | 40 | 54 | $262,407 |
| 2022 | 839 | 18 | 29 | $34,269 |
| 2021 | 119 | 4 | 15 | $5,695 |
See the largest Medicaid services in earlier years
2023
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 636 | $105,623 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 191 | $34,779 |
| EMERGENCY DEPT VISIT MOD MDM | 538 | $32,243 |
| 3D RENDER W/INTRP POSTPROCES | 221 | $12,744 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 233 | $10,399 |
| EMERGENCY DEPT VISIT LOW MDM | 239 | $9,556 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 195 | $7,369 |
| COMPREHENSIVE METABOLIC PANEL | 558 | $5,767 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 188 | $5,529 |
| Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe technique | 188 | $5,330 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism | 188 | $5,309 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 574 | $4,771 |
2022
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 111 | $14,777 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 17 | $4,198 |
| EMERGENCY DEPT VISIT LOW MDM | 55 | $2,560 |
| EMERGENCY DEPT VISIT MOD MDM | 47 | $2,508 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 45 | $2,130 |
| COMPREHENSIVE METABOLIC PANEL | 97 | $1,198 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 29 | $1,053 |
| Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe technique | 29 | $1,053 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism | 29 | $1,053 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 16 | $959 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 85 | $875 |
| Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 28 | $607 |
2021
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 28 | $4,241 |
| EMERGENCY DEPT VISIT LOW MDM | 29 | $1,008 |
| COMPREHENSIVE METABOLIC PANEL | 31 | $253 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 31 | $194 |
Drugs they prescribed that Part D paid
$1,406
Pharmacies billed $1,406 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
117 generic and fewer than 11 brand-name prescriptions · $1,406 in drug cost · 32 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 12 | $148 | $12 |
| Famotidine | 11 | $60 | $5 |
Year by year
| 2024 | 126 | 81 | None | None | $1,406 |
| 2023 | 146 | 87 | None | None | $5,219 |
| 2022 | 955 | 175 | None | None | $74,838 |
| 2021 | 1,096 | 198 | None | None | $96,742 |
| 2020 | 700 | 167 | None | 19% | $71,423 |
| 2019 | 94 | 32 | None | None | $10,721 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Amlodipine Besylate | 11 | $79 | $7 |
2022: 23 drugs
| Combivent Respimat | 16 | $7,844 | $490 |
| Montelukast | 28 | $1,546 | $55 |
| Valsartan | 21 | $1,050 | $50 |
| Albuterol Sulfate Hfa | 26 | $930 | $36 |
| Rosuvastatin | 31 | $883 | $28 |
| Famotidine | 37 | $870 | $24 |
| Amlodipine Besylate | 72 | $729 | $10 |
| Atorvastatin | 52 | $682 | $13 |
| Metoprolol | 24 | $673 | $28 |
| Pravastatin | 19 | $463 | $24 |
| Fluticasone Propionate | 21 | $408 | $19 |
| Hydrochlorothiazide | 45 | $362 | $8 |
| Pantoprazole | 13 | $349 | $27 |
| Levothyroxine | 13 | $297 | $23 |
| Losartan | 22 | $279 | $13 |
| Diclofenac | 13 | $279 | $21 |
| Tamsulosin | 15 | $266 | $18 |
| Hydralazine | 11 | $260 | $24 |
| Clopidogrel | 11 | $205 | $19 |
| Metoprolol | 11 | $145 | $13 |
| Simvastatin | 17 | $124 | $7 |
| Metformin | 23 | $109 | $5 |
| Furosemide | 13 | $82 | $6 |
2021: 29 drugs
| Lantus Solostar | 19 | $11,066 | $582 |
| Jardiance | 11 | $6,387 | $581 |
| Combivent Respimat | 13 | $6,146 | $473 |
| Lantus | 13 | $3,837 | $295 |
| Albuterol Sulfate Hfa | 27 | $1,199 | $44 |
| Famotidine | 42 | $949 | $23 |
| Diclofenac | 20 | $902 | $45 |
| Potassium Chloride | 17 | $836 | $49 |
| Amlodipine Besylate | 84 | $835 | $10 |
| Valsartan | 18 | $772 | $43 |
| Fluticasone Propionate | 30 | $729 | $24 |
| Rosuvastatin | 25 | $577 | $23 |
| Metoprolol | 19 | $464 | $24 |
| Montelukast | 15 | $427 | $28 |
| Pravastatin | 15 | $404 | $27 |
| Atorvastatin | 39 | $385 | $10 |
| Levothyroxine | 12 | $382 | $32 |
| Simvastatin | 27 | $273 | $10 |
| Hydrochlorothiazide | 39 | $267 | $7 |
| Losartan | 13 | $265 | $20 |
| Glipizide | 11 | $217 | $20 |
| Metoprolol | 26 | $215 | $8 |
| Metformin Hcl Er | 12 | $213 | $18 |
| Clonidine | 13 | $196 | $15 |
| Gabapentin | 16 | $180 | $11 |
| Naproxen | 13 | $157 | $12 |
| Furosemide | 16 | $126 | $8 |
| Metformin | 19 | $124 | $7 |
| Losartan-Hydrochlorothiazide | 11 | $124 | $11 |
2020: 17 drugs
| Lantus Solostar | 22 | $10,142 | $461 |
| Atorvastatin | 34 | $424 | $12 |
| Hydralazine | 17 | $386 | $23 |
| Levothyroxine | 12 | $360 | $30 |
| Rosuvastatin | 13 | $239 | $18 |
| Fluticasone Propionate | 13 | $204 | $16 |
| Pravastatin | 13 | $202 | $16 |
| Amlodipine Besylate | 35 | $199 | $6 |
| Famotidine | 13 | $190 | $15 |
| Potassium Chloride | 11 | $190 | $17 |
| Metoprolol | 12 | $160 | $13 |
| Metformin Hcl Er | 14 | $122 | $9 |
| Losartan | 20 | $108 | $5 |
| Hydrochlorothiazide | 14 | $94 | $7 |
| Azithromycin | 15 | $74 | $5 |
| Metformin | 14 | $64 | $5 |
| Metoprolol | 14 | $61 | $4 |
Money from drug and device companies
$57 in 2020
A payment is not proof that care is biased.
| Boston Scientific | Jetstream | $57 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2020-03-10 | Jetstream | $57 |
Professional record
- NPI
- 1790203461
- Licence
- AL MD.41401
- Trained
- Icahn School of Medicine at Mount Sinai, 2017 · 9 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Federal specialty code 101YP2500X (101YP2500X); Federal specialty code 207P00000X (207P00000X); Student in a training program (390200000X)
- Mailing address
- 625 19th St S, Birmingham, AL, 35233
- NPI first listed
- 2017-09-01
- NPI last updated
- 2020-09-02
- NPI record certified
- 2020-09-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1 Gustave L Levy Pl, New York, NY, 10029 · 29360 Belmont Lake Rd, Perrysburg, OH, 43551 · 300 Pasteur Dr, Stanford, CA, 94305